In:
Advanced Healthcare Materials, Wiley, Vol. 11, No. 14 ( 2022-07)
Abstract:
The eye is susceptible to viral infections, causing severe ocular symptoms or even respiratory diseases. Methods capable of protecting the eye from external viral invasion in a long‐term and highly effective way are urgently needed but have been proved to be extremely challenging. Here, a strategy of forming a long‐acting protective ocular surface is described by instilling adhesive dual‐antiviral nanoparticles. Taking pseudotyped severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) as a model virus, antiviral agent‐loaded nanoparticles are coated with a “double‐lock” hybrid cell membrane abundant with integrin‐ β 1 and angiotensin converting enzyme II (ACE2). After instillation, the presence of integrin‐ β 1 endows coated nanoparticles with steady adhesion via specific binding to Arg‐Gly‐Asp sequence on the fibronectin of ocular epithelium, achieving durable retention on the ocular surface. In addition to loaded inhibitors, the exposure of ACE2 can trap SARS‐CoV‐2 and subsequently neutralize the associated spike protein, playing a dual antiviral effect of the resulting nanoparticles. Adhesive dual‐antiviral nanoparticles enabled by coating with a “double‐lock” hybrid cell membrane could be a versatile platform for topical long‐acting protection against viral infection of the eye.
Type of Medium:
Online Resource
ISSN:
2192-2640
,
2192-2659
DOI:
10.1002/adhm.202200283
Language:
English
Publisher:
Wiley
Publication Date:
2022
detail.hit.zdb_id:
2645585-7
Permalink